ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
56 hedge funds and large institutions have $16M invested in Aralez Pharmaceuticals Inc. in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
-7
Holders Change %
-11.11%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
15
Closed
13
Calls
$135K
Puts
$142K
Net Calls
-$7K
Net Calls Change
+$105K
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$498K |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$425K |
| 3 |
Renaissance Technologies
New York
|
+$261K |
| 4 |
SM
Salzhauer Michael
|
+$171K |
| 5 |
BAS
Brown Advisory Securities
Baltimore,
Maryland
|
+$150K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
D.E. Shaw & Co
New York
| – | -$150K | -105,410 | Closed |
|
52
Millennium Management
New York
| – | -$93K | -65,770 | Closed |
|
|
JG
53
Jefferies Group
New York
| – | -$25K | -17,300 | Closed |
|
|
TSS
54
Two Sigma Securities
New York
| – | -$24K | -16,550 | Closed |
|
|
BAM
55
Berkshire Asset Management
Wilkes Barre,
Pennsylvania
| – | -$21K | -15,000 | Closed |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| – | -$7K | -4,916 | Closed |
|
57
UBS Group
Zurich,
Switzerland
| – | -$6K | -4,371 | Closed |
|
|
DOA
58
D'Orazio & Associates
Falls Church,
Virginia
| – | -$1K | -1,006 | Closed |
|